Inhaled Nitrous Oxide

PreclinicalSmall molecule

AAlbert Einstein Healthcare Network

Inhaled Nitrous Oxide is one of 27 small molecule programs targeting Anxiety. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnxietyActive, not recruiting

AnxietyPreclinical

Active, not recruiting

Competition

Competitive Landscape

165 competitors in Anxiety

#DrugCompanyPhaseTrials

Circadin

NNeurim Pharmaceuticals Ltd.

Phase 3

4 2

Duragesic

CCephalon

Phase 3

1 3

Duloxetine Hydrochloride

Eli Lilly

Phase 3

—4

Chamomile

HHams Hamed Abdelrahman

Phase 3

1 5

Celexa

AbbVie

Preclinical

1 6

Spravato

WWim Janssens

Preclinical

4 7

Campral

FForest Laboratories

Preclinical

2 8

Luvox

SSolvay Pharmaceuticals

Preclinical

2 9

Anerem

AAcacia Pharma Ltd

Preclinical

2 10

Catapres

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2028

N/ANot yet recruiting

Anxiety

NCT07491874

Clinical

Trials by Indication[1]

Nitrous Oxide1 trial

Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study

Completed·AAlbert Einstein Healthcare Network·N/A·NCT02145169·20 enrolled

Anxiety1 trial

Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal- A Multicenter Randomized Controlled Study

Not yet recruiting·KKaplan Medical Center·N/A·NCT07491874·60 enrolled

Labor Analgesia1 trial

Inhaled Nitrous Oxide and Labor Analgesia

Terminated·YYa'aqov Abrams·Phase 2·NCT01738672·16 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Inhaled Nitrous Oxide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inhaled Nitrous Oxide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inhaled Nitrous Oxide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Albert Einstein Healthcare Network company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAlbert Einstein Healthcare Network

Inhaled Nitrous Oxide

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2028

Trials by Indication[1]

Nitrous Oxide1 trial

Anxiety1 trial

Labor Analgesia1 trial

References

Drug Info

Quick Facts

Related News